BRIEF-Positive Preliminary Results Demonstrate Autonomix’S Proprietary RF Ablation Technology’S Ability To Reduce Opioid Use In Ongoing Human Clinical Trial

Reuters

2024/10/28

Oct 28 (Reuters) - Autonomix Medical Inc :

* POSITIVE PRELIMINARY RESULTS DEMONSTRATE AUTONOMIX’S PROPRIETARY RF ABLATION TECHNOLOGY’S ABILITY TO REDUCE OPIOID USE IN ONGOING HUMAN CLINICAL TRIAL

* AUTONOMIX MEDICAL INC - TWO PATIENTS SUCCUMBED TO DISEASE POST-PROCEDURE, NOT RELATED TO TRIAL

* AUTONOMIX MEDICAL INC - TRIAL EXPECTED TO COMPLETE ENROLLMENT BY YEAR-END 2024

Source text: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2478104283"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2478104283\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2478104283?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-28 20:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2478104283","market":"us","top_or_hot":-1,"title":"BRIEF-Positive Preliminary Results Demonstrate Autonomix’S Proprietary RF Ablation Technology’S Ability To Reduce Opioid Use In Ongoing Human Clinical Trial","media":"Reuters","content":"<html><body><p>Oct 28 (Reuters) - <a href=\"https://laohu8.com/S/AMIX\">Autonomix Medical Inc</a>   :</p><p>   * POSITIVE PRELIMINARY RESULTS DEMONSTRATE AUTONOMIX’S PROPRIETARY RF ABLATION TECHNOLOGY’S ABILITY TO REDUCE OPIOID USE IN ONGOING HUMAN CLINICAL TRIAL</p><p>   * AUTONOMIX MEDICAL INC - TWO PATIENTS SUCCUMBED TO DISEASE POST-PROCEDURE, NOT RELATED TO TRIAL</p><p>   * AUTONOMIX MEDICAL INC - TRIAL EXPECTED TO COMPLETE ENROLLMENT BY YEAR-END 2024</p><p>Source text:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Positive Preliminary Results Demonstrate Autonomix’S Proprietary RF Ablation Technology’S Ability To Reduce Opioid Use In Ongoing Human Clinical Trial</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Positive Preliminary Results Demonstrate Autonomix’S Proprietary RF Ablation Technology’S Ability To Reduce Opioid Use In Ongoing Human Clinical Trial\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2024-10-28 20:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>Oct 28 (Reuters) - <a href=\"https://laohu8.com/S/AMIX\">Autonomix Medical Inc</a>   :</p><p>   * POSITIVE PRELIMINARY RESULTS DEMONSTRATE AUTONOMIX’S PROPRIETARY RF ABLATION TECHNOLOGY’S ABILITY TO REDUCE OPIOID USE IN ONGOING HUMAN CLINICAL TRIAL</p><p>   * AUTONOMIX MEDICAL INC - TWO PATIENTS SUCCUMBED TO DISEASE POST-PROCEDURE, NOT RELATED TO TRIAL</p><p>   * AUTONOMIX MEDICAL INC - TRIAL EXPECTED TO COMPLETE ENROLLMENT BY YEAR-END 2024</p><p>Source text:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AMIX","symbol_name":"Autonomix Medical Inc","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2478104283","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2478104283","pubTimestamp":1730117295,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Oct 28  - Autonomix Medical Inc   :   * POSITIVE PRELIMINARY RESULTS DEMONSTRATE AUTONOMIX’S PROPRIETARY RF ABLATION TECHNOLOGY’S ABILITY TO REDUCE OPIOID USE IN ONGOING HUMAN CLINICAL TRIAL   * AUTONOMIX MEDICAL INC - TWO PATIENTS SUCCUMBED TO DISEASE POST-PROCEDURE, NOT RELATED TO TRIAL   * AUTONOMIX MEDICAL INC - TRIAL EXPECTED TO COMPLETE ENROLLMENT BY YEAR-END 2024Source text:    Further company coverage:    ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"AMIX":"Autonomix Medical Inc","RF":"地区金融","BK4082":"医疗保健设备","BK4585":"ETF&股票定投概念","BK4211":"区域性银行","BK4588":"碎股","ABIL":"Ability Inc"},"translate_title":"简要-积极的初步结果证明了Autonomix专有的射频消融技术在正在进行的人体临床试验中减少阿片类药物使用的能力","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AMIX":0.9,"RF":1,"ABIL":1},"content_text":"Oct 28 (Reuters) - Autonomix Medical Inc   :   * POSITIVE PRELIMINARY RESULTS DEMONSTRATE AUTONOMIX’S PROPRIETARY RF ABLATION TECHNOLOGY’S ABILITY TO REDUCE OPIOID USE IN ONGOING HUMAN CLINICAL TRIAL   * AUTONOMIX MEDICAL INC - TWO PATIENTS SUCCUMBED TO DISEASE POST-PROCEDURE, NOT RELATED TO TRIAL   * AUTONOMIX MEDICAL INC - TRIAL EXPECTED TO COMPLETE ENROLLMENT BY YEAR-END 2024Source text:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}